We would like to thank the My Name’5 Doddie Foundation for their important statement today regarding the Managed Access Program (MAP) for ILT-101 from Pharma ILTOO.
Whilst we still await the all important results of the Mirocals trial this confirmation that the MAP is now open to non-trial patients is welcome news for our community.
The process for the MAP is documented here on the ILTOO Pharma website and if you are a patient you might wish to explore this option with your consultant.
You may have tried before, but we understand that there is now a greater likelihood that you may be able to receive the treatment candidate under MAP.
Thank you once again My Name’5 Doddie Foundation for working in earnest for our MND community.
#united2endmnd
We are United2EndMND - Changing the conversation 